Bacterial Meningitis Epidemiology and Vaccination

This timely collection of expert papers draws attention to the global burden of meningitis and the challenges faced by the WHO's roadmap to defeat meningitis by 2030. The three main goals of the meningitis roadmap are to eliminate epidemics of bacterial meningitis, reduce cases and deaths from...

Full description

Saved in:
Bibliographic Details
Other Authors: Stuart, James M. (Editor)
Format: Electronic Book Chapter
Language:English
Published: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_76735
005 20220111
003 oapen
006 m o d
007 cr|mn|---annan
008 20220111s2021 xx |||||o ||| 0|eng d
020 |a books978-3-0365-1808-4 
020 |a 9783036518077 
020 |a 9783036518084 
040 |a oapen  |c oapen 
024 7 |a 10.3390/books978-3-0365-1808-4  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a GP  |2 bicssc 
072 7 |a PS  |2 bicssc 
100 1 |a Stuart, James M.  |4 edt 
700 1 |a Stuart, James M.  |4 oth 
245 1 0 |a Bacterial Meningitis  |b Epidemiology and Vaccination 
260 |a Basel, Switzerland  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2021 
300 |a 1 electronic resource (274 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a This timely collection of expert papers draws attention to the global burden of meningitis and the challenges faced by the WHO's roadmap to defeat meningitis by 2030. The three main goals of the meningitis roadmap are to eliminate epidemics of bacterial meningitis, reduce cases and deaths from vaccine-preventable bacterial meningitis, and reduce disability and improve quality of life after meningitis of any cause. This book includes a wide range of original research and reviews on epidemiology and vaccination of bacterial meningitis that have direct relevance to advancing the goals of the roadmap. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Research & information: general  |2 bicssc 
650 7 |a Biology, life sciences  |2 bicssc 
653 |a meningitis 
653 |a child mortality 
653 |a neonatal sepsis 
653 |a global health 
653 |a global health estimates 
653 |a modelling 
653 |a Streptococcus pneumoniae 
653 |a Haemophilus influenzae 
653 |a Neisseria meningitidis 
653 |a bacterial meningitis 
653 |a S. pneumoniae 
653 |a N. meningitidis 
653 |a H. influenzae 
653 |a S. agalactiae 
653 |a conjugate vaccines 
653 |a post-vaccine surveillance 
653 |a vaccine 
653 |a Africa 
653 |a mathematical modelling 
653 |a susceptibility 
653 |a invasive bacterial infections 
653 |a complement 
653 |a genetic factors 
653 |a Streptococcus agalactiae 
653 |a group B streptococci 
653 |a capsule 
653 |a meningococcal group 
653 |a nongroupable 
653 |a meningococcal carriage 
653 |a invasive meningococcal disease 
653 |a meningococcal urethritis 
653 |a neonatal infections 
653 |a epidemiology 
653 |a antibiotic resistance 
653 |a etiologic diagnosis 
653 |a enterovirus 
653 |a group B Streptococcus 
653 |a neurological sequelae 
653 |a hearing loss 
653 |a seizure 
653 |a epilepsy 
653 |a hydrocephalus 
653 |a focal neurological deficit 
653 |a corticosteroid 
653 |a dexamethasone 
653 |a invasive pneumococcal disease 
653 |a pneumococcal conjugate vaccines 
653 |a serotypes 
653 |a vaccine impact 
653 |a pneumococcal meningitis 
653 |a serotype distribution 
653 |a PCV impact 
653 |a global 
653 |a meta-analysis 
653 |a surveillance 
653 |a meningococcus 
653 |a pneumococcus 
653 |a Hib 
653 |a group B streptococcus 
653 |a conjugate vaccine 
653 |a rapid diagnostic test 
653 |a national reference laboratory 
653 |a cerebrospinal fluid 
653 |a Niger 
653 |a Burkina Faso 
653 |a tuberculosis 
653 |a tuberculous meningitis 
653 |a TBM 
653 |a children 
653 |a impact of Hib conjugate vaccine 
653 |a Hia 
653 |a NTHi 
653 |a burden 
653 |a social and economic costs 
653 |a WHO meningitis roadmap 
653 |a disability 
653 |a n/a 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/4184  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/76735  |7 0  |z DOAB: description of the publication